Among the many unanswered questions about calcium pyrophosphate deposition — formerly called “pseudogout” — perhaps the most important is whether it causes osteoarthritis, a speaker said at the Congress of Clinical Rheumatology East.
“I am hoping I can drum up some enthusiasm for what really has been an understudied disease, yet very common,” Sara K. Tedeschi, MD, MPH, co-director of the Fast Track Clinic for Giant Cell Arteritis at Brigham and Women’s Hospital, and assistant professor of medicine at Harvard Medical School, told attendees.
According to